上海金畔生物科技有限公司可以定制不同序列多肽,可以访问官网了解更多产品信息。
名称 | KR-12 (human) |
编码 | [1218951-51-9] |
别名 | KR-12 (human) |
纯度 | 80%,90%,95%,98%,99% |
重量 | 1mg,5mg,10mg,50mg,100mg,1g |
序列(单字母缩写) | KRIVQRIKDFLR-NH2 |
序列(三字母缩写) | H-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-NH2?(trifluoroacetate salt) |
基本描述 | LL-37 is an antimicrobial peptide with angiogenic activity. It corresponds to the C-terminal sequence (134-170) of the human cathelicidin antimicrobial protein hCAP18/LL-37 and is extracellularly released from hCAP18/LL-37 by proteolytic processing. hCAP18/LL-37 is an effector of the innate immune system and is expressed in leukocytes and epithelial cells where it is upregulated in association with inflammation and injury. An overexpression of hCAP18/LL-37 in a series of breast carcinomas could be demonstated. LL-37 has been suggested to stimulate epithelial cell proliferation partially through formyl peptide receptor-like 1 (FPRL1) since blocking the receptor with pertussis toxin decreased the proliferative effect of LL-37 by approximately 50 %. |
溶解度 | |
分子量 | 1570.95 |
化学式 | C71H127N25O15 |
存储条件 | Store at -20°C. Keep tightly closed. Store in a cool dry place. |
注释 | |
Documents | |
Figures | |
Reference | G.Wang, J. Biol. Chem., 283, 32637 (2008) |
C端 | |
N端 | |
化学桥 |